Shopping Cart 0
Cart Subtotal
AED 0

AIDS - Related Primary CNS Lymphoma Global Clinical Trials Review, H2, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 9175

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 18350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 27525

Details

AIDS-Related Primary CNS Lymphoma Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, AIDS-Related Primary CNS Lymphoma Global Clinical Trials Review, H2, 2018" provides an overview of AIDS-Related Primary CNS Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on AIDS-Related Primary CNS Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Clinical Trials by G7 Countries: Proportion of AIDS-Related Primary CNS Lymphoma to Oncology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by Phase 18

Clinical Trials by Trial Status 19

Clinical Trials by End Point Status 20

Clinical Trials by Sponsor Type 21

Prominent Sponsors 22

Prominent Drugs 23

Clinical Trial Profile Snapshots 24

Appendix 30

Abbreviations 30

Definitions 30

Research Methodology 31

Secondary Research 31

About GlobalData 31

Contact Us 32

Disclaimer 32

Source 32


List Of Figure

List of Figures

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Proportion of AIDS-Related Primary CNS Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2018* 14

AIDS-Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

AIDS-Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2018* 18

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 19

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 20

AIDS-Related Primary CNS Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 21

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 23

GlobalData Methodology 31


List Of Table

List of Tables

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Region, 2018* 7

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Proportion of AIDS-Related Primary CNS Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2018* 15

AIDS-Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

AIDS-Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2018* 18

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 19

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 20

AIDS-Related Primary CNS Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 21

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

AIDS - Related Primary CNS Lymphoma Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of AIDS - Related Primary CNS Lymphoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania


Companies

F. Hoffmann-La Roche Ltd

Company Profile

Company Profile Title

AIDS-Related Primary CNS Lymphoma Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, AIDS-Related Primary CNS Lymphoma Global Clinical Trials Review, H2, 2018" provides an overview of AIDS-Related Primary CNS Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on AIDS-Related Primary CNS Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Clinical Trials by G7 Countries: Proportion of AIDS-Related Primary CNS Lymphoma to Oncology Clinical Trials 14

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by Phase 18

Clinical Trials by Trial Status 19

Clinical Trials by End Point Status 20

Clinical Trials by Sponsor Type 21

Prominent Sponsors 22

Prominent Drugs 23

Clinical Trial Profile Snapshots 24

Appendix 30

Abbreviations 30

Definitions 30

Research Methodology 31

Secondary Research 31

About GlobalData 31

Contact Us 32

Disclaimer 32

Source 32


List Of Figure

List of Figures

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Proportion of AIDS-Related Primary CNS Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2018* 14

AIDS-Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

AIDS-Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2018* 18

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 19

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 20

AIDS-Related Primary CNS Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 21

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 23

GlobalData Methodology 31


List Of Table

List of Tables

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Region, 2018* 7

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Proportion of AIDS-Related Primary CNS Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2018* 15

AIDS-Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16

AIDS-Related Primary CNS Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2018* 18

AIDS-Related Primary CNS Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2018* 19

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2018* 20

AIDS-Related Primary CNS Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 21

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22

AIDS-Related Primary CNS Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

AIDS - Related Primary CNS Lymphoma Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of AIDS - Related Primary CNS Lymphoma, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania


Companies

F. Hoffmann-La Roche Ltd